Orally administration of N-acetyl-L-leucine alleviated motor impairments and dopamine neuronal deficits in an animal model of Parkinson’s disease. The findings are consistent with the neuroprotective effects of N-acetyl-L-leucine in several other neurodegenerative disorders.